Department of Carcinogenesis and Oncogerontology, N.N. Petrov National Medical Research Center of Oncology, Pesochny, St. Petersburg, Russia.
Acta Biomed. 2021 Jan 28;92(1):e2021073. doi: 10.23750/abm.v92i1.11273.
The evaluation of the safety of a drug in rodents that may be used as geroprotectors is a challenge of current times. In the paper, we discuss approaches to long-term assays for selection of potent aging delay drugs for humans. Priority is given to methods combining evaluation of carcinogenic safety and life-spanning potential. The use of such methods will be time-efficient and economically feasible.
在啮齿类动物中评估可能用作抗衰老药物的药物的安全性是当前的一个挑战。本文讨论了选择用于人类的强效抗衰老药物的长期检测方法。优先考虑结合评估致癌安全性和寿命延长潜力的方法。使用这种方法将是高效省时且经济可行的。